VILDAGLIPTINE Sandoz cpr 50 mg 28 pce
7680691110016
CH-69111
A10BH02
07.06.2.
Reimbursement limitations:
GALVUS4
Pour le traitement des patients diabétiques de type 2, lorsque un régime alimentaire et une …
1 / 3
google
Details
- Product number
- 6911101
- CPT
- -
- Packaging group
- 28
- Unit
- Tablette(n)
- Composition
- vildagliptinum 50.0 mg, cellulosum microcristallinum, lactosum 47.82 mg, carboxymethylamylum natricum A corresp. natrium max. 0.3 mg, magnesii stearas, pro compresso.
Articles (1)
Vildagliptin Sandoz 50 mg, Tabletten
Tabletten
28
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
47.82 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 27.80
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/06/2023
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 69111
- Drug name
- Vildagliptin Sandoz, Tabletten
- Galenic form
- TAB
- ATC Code
- A10BH02
- Authorization status
- Z
- Authorization category
- Category C
- Dispensation category
- B
- First authorization
- 06/10/2022
- Authorization expiration date
- 31/12/9999
- IT number
- 07.06.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- VILDAGLIPTINE Sandoz cpr 50 mg 28 pce
- Description (DE)
- VILDAGLIPTIN Sandoz Tabl 50 mg 28 Stk
- Market launch
- 06/10/2022
- Narcotic (BTM)
- No